Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies

Military Medical Academy of S.M. Kirov, Saint-Petersburg, Russia Recent clinical trials about the cardiovascular safety of empagliflozin and liraglutide demonstrated a convincing lowering effect on mortality from cardiovascular causes among the patients with type 2 diabetes. These findings resulted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladimir V. Salukhov, Yurii Sh. Khalimov, Sergey B. Shustov, Dmitriy V. Kadin
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2018
Materias:
Acceso en línea:https://doaj.org/article/0938f70fe352468e937a00e32e7e3b3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!